DCD and breast carcinoma: Thereafter, several research groups reported additional evidence concerning this protein in various types of cancers, as illustrated in Figure 7: Intracellular or extracellular overexpression of dermcidin in breast cancer [52], gastric cancer [53,54], hepatocellular carcinoma [55,56], lung cancer [57,58], melanoma [59,60], and pancreatic cancer [61]; promotion of cell survival [48,51,62,63,64]; and promotion of cell migration [55,65].